Board of Governors
Biographies of our Board of Governors, who guide and oversee Wellcome's activities.
Our Board of Governors has ultimate responsibility for Wellcome's activities.
Chair
Date of appointment: 12 April 2021
The first woman to serve as Australia’s Deputy Prime Minister and Prime Minister (2007-2013), Julia was central to the successful management of Australia’s economy following the global financial crisis. She delivered nation-changing policies, including the reform of education, emissions trading, and the provision and sustainability of healthcare. In 2017, Julia was awarded a Companion of the Order of Australia.
Julia currently serves as the Chair of Global Partnership for Education, a leading organisation dedicated to expanding access and quality education worldwide, and Beyond Blue, Australia’s leading mental health awareness body.
In April 2018, she was appointed Inaugural Chair of the Global Institute for Women’s Leadership at King's College London. She is also Patron of Camfed, the Campaign for Female Education.
Prior to entering the Australian Federal Parliament, Julia worked as an industrial relations lawyer, and as Chief of Staff to the Premier of Victoria, Australia.
AC: Companion of the Order of Australia
Deputy Chair
Date of appointment: 1 January 2012
Mike Ferguson is Regius Professor of Life Sciences and academic lead for Research Strategy in the School of Life Sciences at the University of Dundee. His personal research takes a multidisciplinary approach to understanding the biochemistry of protozoan parasites that cause tropical diseases. He believes in the fundamental importance of working across the biology-chemistry interface and in interdisciplinary research in general.
He is particularly interested in translational research and, together with his colleagues, established the Drug Discovery Unit at the University of Dundee and led the construction of the Discovery Centre (for Translational and Interdisciplinary Research).
He also co-directs a proteomics facility that supports much of the work of his colleagues in the Schools of Life Sciences and Medicine.
Mike was knighted in 2019 for his services to science.
CBE: Commander of the Order of the British Empire
FRS: Fellow of the Royal Society
FRSE: Fellow of the Royal Society of Edinburgh
FMedSci: Fellow of the Academy of Medical Sciences
Date of appointment: 1 May 2021
Arup K. Chakraborty is one of 12 Institute Professors at the Massachusetts Institute of Technology (MIT), which is the highest honour awarded to a faculty member. He is also Professor of Chemical Engineering, Physics, and Chemistry. He was the founding director of MIT’s Institute for Medical Engineering and Science.
With a background in chemical engineering, Arup's focus is on the intersection between immunology, physics and engineering. His work aims to help develop better vaccines and therapies by examining how the immune system works to combat pathogens. He is particularly interested in the human immune response to highly mutable pathogens such as HIV and influenza. He has also made significant contributions to the role of phase separation in transcription. Working with collaborators, his interdisciplinary lab at MIT brings together computational studies rooted in statistical physics with clinical and experimental investigation.
He is a member of all three branches of the US National Academies: the National Academy of Sciences, the National Academy of Engineering, and the National Academy of Medicine.
Date of appointment: 1 September 2019
Amelia Fawcett, a former investment banker and lawyer, has a career spanning financial services, media and telecommunications, investment management and government. In addition to 20 years at Morgan Stanley, she has extensive board experience including at the Standards Board for Alternative Investments, the Guardian Media Group, The Prince of Wales’s Charitable Foundation, the UK Treasury, the Court of the Bank of England and the London Business School.
Currently, she is the lead director of State Street Corporation in the USA, Chair of Kinnevik AB in Sweden and Chair of Royal Botanic Gardens Kew.
DBE: Dame Commander of the Order of the British Empire
CVO: Commander of the Royal Victorian Order
Date of appointment: 1 September 2019
Richard Gillingwater is currently the Chair of Janus Henderson, a global asset manager. After a career in finance, he set up and ran UK Government Investments, created to manage the government’s state-owned businesses, and chaired the UK’s development finance business, CDC, investing in Africa and Asia. He has also served as Dean of Cass Business School and as Chair of the Open University and has wide board experience.
CBE: Commander of the Order of the British Empire
Date of appointment: 1 May 2021
Gabriel Leung is Dean of Medicine and inaugural Helen and Francis Zimmern Professor in Population Health at the University of Hong Kong (HKU). He is one of Asia’s leading epidemiologists, with extensive experience in viral epidemics.
Gabriel’s career has spanned academia and public service. Previously, he was Head of Community Medicine at HKU, and Hong Kong's first Under Secretary for Food and Health. He also served as the youngest ever Director of the Office of the Chief Executive of Hong Kong.
He is a member of the US National Academy of Medicine and was awarded the Gold Bauhinia Star by the Government of Hong Kong.
GBS: Gold Bauhinia Star
Date of appointment: 1 January 2018
Fiona Powrie is Director of the Kennedy Institute of Rheumatology, University of Oxford. She gained a PhD in immunology from the University of Oxford and then moved to the DNAX Research Institute in Palo Alto. She returned to the University of Oxford in 1996 where she was the Sidney Truelove Professor of Gastroenterology and Head of the Translational Gastroenterology Unit from 2009-2014.
Fiona’s research is focused on interactions between the intestinal microbiome and the immune system. She identified the role of regulatory T cells in controlling intestinal inflammation and established the cytokine IL-23 as a therapeutic target in inflammatory bowel disease. She is particularly interested in translating basic research into clinical application. She leads the Oxford Biomedical Research Centre’s Gastroenterology and Mucosal Immunology theme and recently established the Accelerated Therapy for Arthritis Programme, a clinical research network designed to increase the testing of novel therapies in the clinic.
She serves on a number of scientific advisory boards including the Lister Institute, the Imagine Institute in Paris and the Evergrande Centre in Boston. She received the Louis Jeantet Prize for Medicine in 2012 and was elected a Fellow of the Royal Society in 2011, EMBO in 2013, the Academy of Medical Sciences in 2014 and the US National Academy of Sciences in 2020.
FRS: Fellow of the Royal Society
FMedSci: Fellow of the Academy of Medical Sciences
Date of appointment: 1 September 2019
Cilla Snowball has had a long career in advertising, including 26 years at the creative agency AMV BBDO, where she was Group CEO and Group Chairman, and pivotal in making it one of the most successful advertising agencies in the UK.
She has chaired the Women’s Business Council, the GREAT Private Sector Council, acted as a trustee of Comic Relief, and is a Non-Executive Director at the property investment and development company Derwent London plc.
DBE: Dame Commander of the Order of the British Empire
Date of appointment: 1 January 2020
Elhadj As Sy is the Chair of the Kofi Annan Foundation Board, and Co-chair of the WHO/World Bank Global Pandemic Preparedness Monitoring Board (GPMB). In addition to these functions, Mr. Sy is also a member of the Governing Board of Interpeace and serves on numerous other boards and organisations.
Mr. Sy has over 30 years’ experience of leadership in the humanitarian, health, environment and development sectors, and has previously served as the Secretary General of the International Federation of Red Cross and Red Crescent Societies (IFRC) – the world’s largest humanitarian network.
Prior to this appointment, Mr. Sy was UNICEF’s Director of Partnerships and Resource Development in New York. He has also served as UNICEF Regional Director for Eastern and Southern Africa, Global Emergency Coordinator for the Horn of Africa, and at senior levels of other agencies including UNAIDS, and the Global Fund to Fight AIDS, Tuberculosis and Malaria.
Date of appointment: 1 November 2021
Ijeoma Uchegbu is a Professor of Pharmaceutical Nanoscience at UCL (University College London), a Fellow of the Academy of Medical Sciences and a member of the Scientific Advisory Board of the Oxford Centre for Drug Delivery Devices at the University of Oxford. She is also the Chief Scientific Officer and Co-founder of Nanomerics, a speciality pharmaceutical company that seeks to create better medicines by enhancing and repurposing existing drugs.
Ijeoma has a background in physical science, which informs her work stretching from the molecular design of pharmaceuticals through to how these products work in the real world. Her research team has successfully designed nanosystems which deliver genes to tumours and facilitate the oral absorption of hydrophobic drugs.
Starting her career as a pharmacist in Nigeria, she later went on to study for a PhD from the School of Pharmacy, University of London. Ijeoma also has well-established experience of working in an advisory capacity on race equality as Co-chair of UCL’s Race Equality Steering Group and UCL Provost’s envoy for Race Equality.
She is a Council member of the Biotechnology and Biological Sciences Research Council (BBSRC) and Editor of the Journal of Pharmaceutical Sciences. In 2012, she was awarded Scientist of the Year by the Royal Pharmaceutical Society.
FMedSci: Fellow of the Academy of Medical Sciences
FAAS: Fellow of the African Academy of Sciences
